Episodes: 203
Frequency: Irregular
Rating: 4.5/5.0
Estimated listeners: 1k-10k
Gender skew: Unknown
Location: USA
YouTube: 297.0k subscribers
Instagram: 207.0k followers
Publicly listed emails
content+a16zpodcast@a16z.com
Looking for the right person? Join Podseeker to find direct host and producer contacts and manage your podcast outreach.
Vineeta Agarwala - General Partner at Andreessen Horowitz focused on biotechnology and healthcare investments and company building.
Julie Yoo - General Partner at Andreessen Horowitz focused on healthcare technology, entrepreneurship, and company building.
Jorge Conde - General Partner at Andreessen Horowitz focused on biotechnology, healthcare, and technology companies.
Stéphane Bancel - Personalized Cancer Vaccines, Mrna Technology, Individualized Medicine Manufacturing, Oncology, And Applications Of Mrna To Rare Genetic And Autoimmune Diseases.
Suchi Saria - Clinical AI, Proactive Care, FDA Approval, Reimbursement, Clinical Evidence, AI Governance, Clinician Trust, And Healthcare Workflow Integration.
Nicolás Abad - Ai-assisted Medicine, Clinical Documentation, Electronic Health Records, Medical Errors, Healthcare Access, And Technology-enabled Care Delivery In Latin America.
Andrew Huberman - Peptides, Glp-related Treatments, Consumer Health, Sleep Technology, Focus Drugs, And Neurotechnology.
Moderna CEO Stéphane Bancel on the Next Era of mRNA
September 02, 2026
a16z General Partner Jorge Conde sits down with Moderna CEO Stéphane Bancel to discuss a major milestone for mRNA technology: positive Phase 3 results from Moderna and Merck’s individualized treatment for melanoma, after more than a decade of work on personalized cancer vaccines. Stéphane explains how the treatment works by sequencing an individual patient’s tumor and healthy cells, identifying the mutations most relevant to their cancer, and encoding up to 34 of them into an mRNA designed sp...
Clinical AI Comes of Age | Suchi Saria on the Future of Healthcare
July 06, 2026
Julie Yoo sits down with Dr. Suchi Saria, founder and CEO of Bayesian Health, to discuss the current state of clinical AI and what it takes to deploy AI systems in real-world healthcare settings. While much of the recent attention around AI has focused on copilots, chatbots, and administrative workflows, Saria argues that the greatest opportunity lies in helping clinicians make better decisions at the point of care. She explains how Bayesian Health's clinical intelligence platform continuousl...
AI, Healthcare, and 700 Million Patients | Nicolas Abad, Telepatía
June 17, 2026
Nicolás Abad, founder and CEO of Telepatía, joins a16z to discuss building AI-powered tools for healthcare in Latin America. Inspired by the loss of his father to a preventable medical error, Adbad set out to address one of the region’s most significant challenges: a shortage of doctors, fragmented medical records, and limited healthcare infrastructure across a population of more than 700 million people. Telepatía's first product acts as a clinical copilot, helping physicians document visits,...
Publicly listed emails
content+a16zpodcast@a16z.com
Looking for the right person? Join Podseeker to find direct host and producer contacts and manage your podcast outreach.
Try us risk free with a FREE 3 days trial.
Join hundreds of PR teams using Podseeker to pitch and land bookings